Health Care Select Sector SPDR® ETF (XLV)
80.46
-0.51 -0.62%
NYSE Arca
Jul 25, 14:51
Delayed 2m
USD
XLV Key Stats
| Expense Ratio | 0.14% |
| Share Class Assets Under Management | 18.12B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 80.90 |
| Discount or Premium to NAV | 0.07% |
| Turnover Ratio | 8.00 |
View All XLV News
XLV News
-
WireHeadlineTime (ET)
-
MT Newswires07/25 13:39
-
Yahoo07/25 12:55
-
Yahoo07/25 11:44
-
MT Newswires07/25 09:27
-
Yahoo07/25 09:13
-
Yahoo07/25 06:51
-
Yahoo07/24 17:35
-
MT Newswires07/24 13:30
-
Yahoo07/24 12:43
-
Yahoo07/24 11:05
XLV Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | 0.61% | 1.75% | 77 |
| 3M | 9.23% | 11.01% | 65 |
| 6M | 18.11% | 18.57% | 69 |
| 1Y | 9.68% | 14.04% | 73 |
| 3Y | 10.91% | 10.65% | 40 |
| 5Y | 18.58% | 17.83% | 53 |
| 10Y | 10.64% | 11.65% | 65 |
Returns for periods of 1 year and above are annualized.
XLV Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.11% | 0.11% | 0.00 |
| Stock | 99.89% | 99.89% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | 0.00 | 0.00 | 0.00 |
XLV Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00 |
| Greater Europe | 0.00 |
| United Kingdom | 0.00 |
| Europe Developed | 0.00 |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 0.00 |
| Japan | 0.00 |
| Australasia | 0.00 |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00 |
Region breakdown data is calculated by using the long position holdings of the portfolio.
XLV Stock Sector Exposure
| Basic Materials | 0.00 |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 99.38% |
| Industrials | 0.00 |
| Real Estate | 0.00 |
| Technology | 0.62% |
| Utilities | 0.00 |
XLV Stock Market Capitalization
| Giant | 54.05% |
| Large | 36.94% |
| Medium | 9.01% |
| Small | 0.00 |
| Micro | 0.00 |
XLV Stock Style Exposure
| Large Cap Value | 32.24% |
| Large Cap Blend | 20.23% |
| Large Cap Growth | 38.53% |
| Mid Cap Value | 1.17% |
| Mid Cap Blend | 3.87% |
| Mid Cap Growth | 3.97% |
| Small Cap Value | 0.00 |
| Small Cap Blend | 0.00 |
| Small Cap Growth | 0.00 |
View More Holdings
As of July 21, 2017
XLV Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 11.80% | 131.91 | -0.83% |
| PFE | Pfizer Inc | 6.46% | 33.12 | -0.60% |
| UNH | UnitedHealth Group Inc | 6.03% | 190.85 | -0.02% |
| MRK | Merck & Co Inc | 5.54% | 62.29 | -0.45% |
| AMGN | Amgen Inc | 4.29% | 180.88 | -0.10% |
| ABBV | AbbVie Inc | 3.84% | 72.73 | -1.60% |
| MDT | Medtronic PLC | 3.79% | 85.81 | +0.85% |
| CELG | Celgene Corp | 3.48% | 136.87 | -0.70% |
| GILD | Gilead Sciences Inc | 3.12% | 74.18 | -0.28% |
| BMY | Bristol-Myers Squibb Company | 2.98% | 55.98 | +0.68% |
Advertisement
XLV One Page Reports
- One Page Report Download
XLV Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Benchmark Index | |
|---|---|
S&P Health Care Select Sector TR USD |
100.0% |
XLV Manager Info
| Name | Tenure |
|---|---|
| Dwayne Hancock | 0.32 yrs |
| Karl Schneider | 2.25 yrs |
| Michael Feehily | 6.25 yrs |
XLV Net Fund Flows
| 1M | 680.87M |
| 3M | 664.15M |
| 6M | 1.887B |
| YTD | 1.887B |
| 1Y | 3.455B |
| 3Y | 4.336B |
| 5Y | 6.459B |
| 10Y | 8.618B |
XLV Risk Info
| Beta (5Y) | 0.9158 |
| Max Drawdown (All) | 40.58% |
| Historical Sharpe (10Y) | 0.7721 |
| Historical Sortino (All) | 0.7065 |
| 30-Day Rolling Volatility | 9.31% |
| Daily Value at Risk (VaR) 1% (All) | 3.04% |
| Monthly Value at Risk (VaR) 1% (All) | 13.34% |
XLV Fundamentals
| Dividend Yield TTM (7-25-17) | 1.45% |
| SEC Yield (7-21-17) | 1.42% |
| Weighted Average PE Ratio | 23.48 |
| Weighted Average Price to Sales Ratio | 1.874 |
| Weighted Average Price to Book Ratio | 3.911 |
| Weighted Median ROE | 22.65% |
| Weighted Median ROA | 8.16% |
| Forecasted Dividend Yield | 1.68% |
| Forecasted PE Ratio | 20.75 |
| Forecasted Price to Sales Ratio | 1.736 |
| Forecasted Price to Book Ratio | 3.365 |
| Number of Holdings | 62 |
XLV Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.09% |
| Forecasted Book Value Growth | 9.17% |
| Forecasted Cash Flow Growth | 14.51% |
| Forecasted Earnings Growth | 11.86% |
| Forecasted Revenue Growth | 9.93% |
XLV Comparables
EditXLV Attributes
| Key Dates | |
|---|---|
| Inception Date | 12/16/1998 |
| Last Annual Report Date | 9/30/2016 |
| Last Prospectus Date | 1/31/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | Yes |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
XLV Excel Add-In Codes
- Name: =YCI("XLV","name")
- Broad Asset Class: =YCI("XLV", "broad_asset_class")
- Broad Category: =YCI("XLV", "broad_category_group")
- Prospectus Objective: =YCI("XLV", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
